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Glass compositions were carefully prepared, using natural quartz and potassium feldspar as a part 
of the starting raw materials. The solids were prepared so as to have theoretical stoichiometric leucite 
and 45S5 Bioglass in different L/Bg weight ratios between 0.43-1.00. Novel bioactive glass-ceramics, 
containing leucite, sodium calcium silicate and silicorhenanite, confirmed by XRD and FTIR, were 
obtained. Bioactivity tests were carried out on powdered and sintered disks forms. The immersion 
time was up to 25 days. Apatite formation on powders was studied by FTIR, and XRD and SEM were 
used to study bioactivity on disks. The materials developed an apatite layer on their surfaces within 
6 days of immersion in simulated body fluid. The glass-ceramic with L/Bg ratio= 0.43 presented an 
apatite layer on all its surface, not so for the samples with 0.66 and 1.00 ratios, on which such layer 
was peeled off in most part of their surfaces.
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1. Introduction
Bioglass 45S5 is the best known bioceramic and 
the most used in clinical applications for its rapid 
hydroxycarbonate apatite (HCA) layer formation which 
allows bone tissue bonding. In spite of these advantages, it 
has some drawbacks such as its low mechanical resistance 
and its high dissolution rate. A good mechanical resistance 
and a controlled dissolution rate are necessary key properties 
in tissue engineering. A way to solve this problem and 
control degradation rate is heat treating Bioglass so as to 
turns it into a glass-ceramic. The latter slightly decreases the 
kinetics of HA formation without suppressing its bioactivity, 
as it has been demonstrated by many authors1-4. Another 
form to fulfill the mechanical resistant requirements is by 
carefully designing the composition of the precursor glass so 
that it develops, together with thermal treatment, crystalline 
phases which reinforce the material. Aluminum addition is 
another way to improve mechanical properties and control 
the degradation rate of glass, but it cannot surpass 3 % w/w, 
otherwise, it inhibits bone bonding5. Nevertheless, if Al 
ions are part of a crystalline phase, there is no interference 
with the bioactivity, as is the case of mica-apatite glass-
ceramics6,7. All of these materials are mostly produced from 
analytical grade raw materials.
Leucite is widely used in dental glass-ceramics as a 
reinforcing phase8. Studies have been made to evaluate 
bioactive glass-ceramics composites containing leucite for 
dental application9,10. In this work, it was able to produce 
glass-ceramics containing sodium calcium silicate and 
leucite as mayor phases, but not by mixing two glasses that 
have different composition, as it is the case of glass-ceramics 
composites. To our knowledge, there is no research not only 
on bioactive glass-ceramics containing leucite that was not 
produced from composites, neither on using natural minerals 
as starting materials.
The aim of this work was to strategically prepare glasses 
that develop leucite crystals using natural minerals and 
analytical grade raw materials as well as to evaluate glass-
ceramics bioactivity.
2. Experimental
2.1. Sample preparation
The raw materials used were analytical grade sodium 
carbonate, calcium carbonate, monobasic ammonium 
phosphate (Anedra) and potassium carbonate (Biopack); and 
high purity natural quartz and potassium feldspar provided 
by a national mining company. Table 1 shows the chemical 
analyses of the natural raw materials.
Glass compositions were prepared so as to have 
theoretical weight ratios of stoichiometric leucite (KAlSi2O6) 
and 45S5 Bioglass between 0.43-1.00. In this way, three 
glasses were produced: L30Bg70 (L/Bg=0.43), L40Bg60 
(L/Bg=0.66) and L50Bg50 (L/Bg=1.00), where the number 
next to L is the theoretical weight percentage of Leucite and 
the number next to Bg is the theoretical weight percentage of 
Bioglass 45S5. All mixtures were prepared using a ball mill 
with ethanol during one hour. The mixtures were pre-treated 
for decarbonation for 4 hours at 900 °C. Glass frits were 
produced by melting at 1550 °C for one hour and quenched 
into distilled water. Frits were milled into porcelain mortar 
and passed through 200 mesh. Glass-ceramics powder 
were produced by heat-treating loose glass powders onto 
platinum plates, grounded into porcelain mortar and then 
sieved through 100 mesh. Glass-ceramics disks were 
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produced by heat treatment of glass powders pressed up to 
140 MPa in cylindrical shape. These heat treatments were 
the same for powders and disks and were performed at a 
heating rate of 2 °C per minute up to each glass softening 
temperature, which were obtained by thermal analyses (920, 
990 and 1000 °C for L30Bg70, L40Bg60 and L50Bg50, 
respectively), holding the temperature for 2 hours.
2.2. Bioactivity test
Glass-ceramics in powders and disks forms were 
assessed in simulated body fluid (SBF) for 6 and 25 days. 
The solid/solution ratios were 1mg/cm3 for powders and 
0.1cm–1 for disks. The solution was renewed every 5 days. 
Simulated body fluid was prepared following the recipe 
given by Kokubo et al.11.
2.3. XRD
Glass-ceramic disks before and after assessment in 
simulated body fluid and powder glass-ceramics after 
thermal treatments were characterized by X-ray diffraction 
on a Philips 3010 equipment using Cu Kα radiation 
(λ = 1.5405 Å) at 40kV and 35 mA. Powdered glass-
ceramics diffractograms were obtained using a step of 
0.04 °(2θ) and 2 seconds per step, from 10 to 70 °(2θ), 
for crystalline phase determination. Diffractograms of the 
surfaces of glass-ceramics disks were obtained using a 
step of 0.03 °(2θ) and 4 seconds per step, from 22.49 to 
35.00 °(2θ), to get more sensibility for apatite detection.
2.4. FTIR
Fourier transformed infrared spectra (4000-380 cm–1) 
of powered glass-ceramics before and after SBF immersion 
were measured by using Spectrum One Perkin Elmer 
equipment in transmittance mode. The samples were 
dispersed in KBr (1% mass) and compacted in a thin pellet 
form.
2.5. SEM
The surfaces of reacted and unreacted glass-ceramics 
disks were observed using a scanning electron microscope 
FEI Quanta 200, at 20 kV and low vacuum. The Ca/P ratios 
of the formed layers were analyzed by EDAX. Samples did 
not have additional coating for the analyses.
3. Results
3.1. X‑Ray diffraction
X-ray diffraction of L30Bg70, L40Bg60 and L50Bg50 
glass-ceramics powders are shown in Figure 1. All samples 
crystallized after the corresponding thermal treatment. It 
was found that peaks positions and intensities match with 
Na2CaSi2O6 pattern (sodium calcium silicate), KAlSi2O6 
(leucite) and Na2Ca4(PO4)2SiO4 (silicorhenanite) phases. 
Both Na2CaSi2O6 and Na2Ca4(PO4)2SiO4 were found 
after thermal treatment of Bioglass 45S512,13. As it can 
be observed, the relative intensities of the major phases, 
Na2CaSi2O6 and KAlSi2O6, were different in each sample. 
The relative peaks intensities of sodium calcium silicate 
increased, while leucite intensities decreased with the 
theoretical quantity of Bioglass in composition.
XRD of the surfaces of L30Bg70, L40Bg60 and 
L50Bg50 glass-ceramics disks before and after assessment 
in SBF are shown in Figure 2. In theses cases, silicorhenanite 
peaks could not be detected. All glass-ceramics showed a 
decrease on sodium calcium silicate peaks intensities vs 
Figure 1. XRD of glass-ceramics in powder form: a: L30Bg70; b: 
L40Bg60; c: L50Bg50. L: leucite; ncs: sodium calcium silicate; 
sr: silicorhenanite.
Figure 2. XRD of disk glass-ceramics: before (a0: L30Bg70; b0: 
L40Bg60; c0: L50Bg50) and after 6 (a1: L30Bg70; b1: L40Bg60; c1: 
L50Bg50) and 25 (a2: L30Bg70; b2: L40Bg60; c2: L50Bg50) days 
of immersion in SBF solutions. L: leucite; ncs: sodium calcium 
silicate; A: apatite.
Table 1. Chemical analyses of natural raw materials.
Raw Material SiO2 Al2O3 Na2O K2O CaO Fe2O3 TiO2
Feldspar 66.25 18.42 2.06 12.02 0.20 0.05 0.01
Quartz 99.33 0.49 0.06 0.10 0.00 0.01 0.00
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assessed time in SBF. After the 6th day, the diffracted peaks 
of sodium calcium silicate in L30Bg70 almost disappeared, 
while for L40Bg60 and L50Bg50, the peaks of this phase 
were diminished but remained well-visible. The intensities 
of leucite peaks were slightly diminished on L30Bg70 and 
L40Bg60 samples, while there was not a noticeable chance 
in L50Bg50.
After the 25th day of assessment, the diffraction peaks 
of sodium calcium silicate were no more detectable in 
glass-ceramic L30Bg70, while the intensities decreased 
a little more in L40Bg60 and L50Bg50, but still were 
distinguishable. Leucite peaks in L30Bg70 were more 
reduced, except for that at around 26° (2θ) which increased 
and corresponds to the (0 0 2) plane of hydroxyapatite, and 
a broad hallo appeared at around 32° which is the result of 
the contribution of the (2 2 1), (1 1 2), and (2 0 2) planes of 
apatite14. This affirmed the establishment of a well-formed 
hydroxyapatite layer on the surface of L30Bg70 specimen. 
In contrast, L40Bg60 showed a little more reduction in 
all leucite intensities and no difference was observed 
on L50Bg50 with timeless immersions in SBF. Apatite 
formation was not possible to perceive by X-ray diffraction 
on L40Bg60 and L50Bg50.
3.2. FTIR
Figure 3 shows the Fourier transformed infrared spectra 
of L30Bg70, L40Bg60 and L50Bg50 glass-ceramics before 
and after assessment in simulated body fluid.
The unreacted L30Bg70 glass-ceramic showed bands 
at 1100-1000 cm–1, 950-900 cm–1 and 443 cm–1 attributed 
to Si-O-Si, Si-O (NBO)1,15 stretching, and Si-O-Si bending 
vibrations1, respectively, as well as a band at 619 cm–1, 
all associated with sodium calcium silicate phase16. The 
presence of leucite was evident by the appearance of the 
band located at 720 cm–1[17], and a broadband at 500-560 cm–1 
which coincides also with the contribution of PO bending 
vibrations of silicorhenanite18. The band at 577 cm–1 
corresponds to a crystalline PO bending vibrational mode, 
which can be also attributed to silicorhenanite18,19.
Glass-ceramic L40Bg60 showed similar bands to those 
described for L30Bg70, apart from two shoulders at 412 
and 642 cm–1[17], which were attributed to the presence of 
leucite. A similar behavior was observed in the L50Bg50 
glass-ceramic, in which the band at 720 cm–1 was intensified 
and the shoulder at 642 cm–1 was even more marked, which 
corresponds to a higher relative content of leucite.
After dipping the L30Bg70 glass-ceramic powder for 
6 days in SBF, it was observed that the bands corresponding 
to sodium calcium silicate (1090, 920, 619 and 443 cm–1) 
and silicorhenanite (577 cm–1) were not visible. At the same 
time, two shoulders could be seen at 542 and 642 cm–1, 
corresponding to vibrational bands of leucite17, which 
were previously overlapped with the bands of sodium 
calcium silicate. New bands appeared at 562 and 602 cm1 
corresponding to PO bendings vibrations20, two shoulders 
at 960 cm–1[21] and 1120 cm–1[2] related to PO vibrational 
modes, and an intense band at 1030 cm–1, related to different 
vibrational modes of PO4–3[9], all attributed to the formation 
of crystalline hydroxyapatite5. Two bands were observed at 
876 and 1422 cm-1 corresponding to carbonate substitutions 
into hydroxyapatite9.
L40Bg60 and L50Bg50 glass-ceramics contacted with 
SBF for 6 days displayed similar behavior to that described 
for L30Bg70, with some particularities. In the IR spectrum 
of reacted L40Bg60, we could see that the bands at 542 and 
642 cm–1, corresponding to leucite, were more visible and 
those related to carbonate substitutions into hydroxyapatite 
decreased in intensity with respect to the behavior of the 
sample L30Bg70 for the same contact time. These particular 
differences were intensified in L50Bg50 sample contacted 
with SBF.
3.3. SEM
Scanning electron microscope images of the surfaces 
of glass-ceramics disks before and after assessment in 
simulated body fluid at different times are displayed in 
Figures 4, 5 and 6. The three glass-ceramics surfaces before 
SBF contact have homogeneous characteristics. L30Bg70 
glass ceramics presented a rather smooth surface, with a 
poor rugosity, where glass precursor particles were almost 
undistinguishable. L40Bg60 and L50Bg50 glass-ceramics 
showed a more roughened surface than L30Bg70 glass 
ceramic, with more defined particles with round shapes. 
After 6 days of immersion, L30Bg70 specimen presented 
spherical particles of hydroxyapatite that agglomerated and 
formed a thin smooth layer, with some particles standing out. 
Chen et. al. found that 45S5 Bioglass-derived glass-ceramics 
scaffolds formed a HCA layer after 7 days of immersion in 
SFB22. The layer copied the microstructure of the specimen 
surface and presented cracks, which usually appear because 
of the shrinking of silica-rich layer when dried, onto which 
the apatite layer grows. For L40Bg60 and L50Bg50, apatite 
layer was formed too, but it was only possible to find it close 
to the edge of the disks, because there was not well adherence 
to the surface and it had peeled off. The layer had many cracks 
and it was characterized by a rough morphology of spherical 
agglomerated apatite particles in both samples. On the 25th 
day, L30Bg70 had a visibly thicker apatite layer and was even 
smoother so the morphology of the sample surface was no 
Figure 3. Infrared spectra of glass-ceramics before (a0: L30Bg70; 
b0: L40Bg60; c0: L50Bg50) and after 6 (a1: L30Bg70; b1: L40Bg60; 
c1: L50Bg50) days of immersion in SBF solutions.
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Figure 4. SEM and EDAX of L30Bg70 glass ceramic before (a0) and after 6 (a1) and 25 (a2) days of immersion in SBF.
more noticeable. The layer of L40Bg60 and L50Bg50 glass-
ceramics after 25 days of immersion had a lot of outbound 
apatite particles and the layer was very rough. Again, the 
layer was only found in some places for both specimens. In 
all cases, Ca/P ratios of hydroxyapatite particles and layer 
were in the range of 1.39-1.58 which indicated the presence 
of Ca-deficient apatite. This was an important fact since the 
Ca/P ratio of bone tissue is below 1.6723,24.
2014; 17(4) 1035Bioactivity of Leucite Containing Glass-ceramics Using Natural Raw Materials
Figure 5. SEM and EDAX of L40Bg60 glass ceramic before (b0) and after 6 (b1) and 25 (b2) days of immersion in SBF.
4. Discussion
Thermal treatments applied to each glass caused the 
formation of sintered glass-ceramics. In all cases, the 
crystallized phases were Na2CaSi2O6), Na2Ca4(PO4)2SiO4, 
both developed after thermal treatment of Bioglass12,13 
and KAlSi2O6. Leucite formation was possible by 
treating the glass in powder form, which activated the 
surface crystallization mechanism of the aluminosilicate 
phase25. Sodium calcium silicate was formed by surface 
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Figure 6. SEM and EDAX of L50Bg50 glass ceramic before (c0) and after 6 (c1) and 25 (c2) days of immersion in SBF.
but not by volume mechanism. The small particle size 
of precursor glasses promoted surface over volume 
crystallization26. Detection of the silicate phase by XRD 
on the surfaces of all samples, which was not hindered 
by the surface crystallization of leucite, demonstrated this 
fact. Nevertheless, silicorhenanite was indeed obstructed 
by surface crystallization, as its diffraction peaks were 
not detectable in glass-ceramics disks. As it was expected, 
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amounts of leucite and sodium calcium silicate decreased 
and increased respectively with the quantity of Bioglass 
in the mix.
All samples demonstrated bioactive behavior after 
6 days of contact with simulated body fluid in both powdered 
and sintered disk forms. A well former apatite layer was 
crystallized in all glass-ceramics in powder form, as it was 
shown by FTIR. Apatite layer was possible to be detected 
by SEM at the 6th day in all sintered samples. This layer 
in L30Bg70 was not thick enough to be detected by X-ray 
diffraction. A well-formed and thick enough layer was 
crystallized on the surface of L30Bg70 glass-ceramic after 
25 days of immersion, as it was found by X-ray diffraction. 
L30Bg70 had the highest amount of sodium calcium silicate, 
which was dissolved in contact with SBF and contributed 
to the HCA formation13, and the lowest amount of non-
bioactive leucite of all samples, which could explain its 
good bioactive behavior. The apatite layer in L40Bg60 and 
L50Bg50 was not present in all surface after 6 and 25 days 
of immersion, because it had peeled off, due to the quantity 
of non-bioactive leucite27 and it was only found in some 
places. That is why the HCA layer was not detected by XRD 
because it was absent in most of the surface. Nevertheless, 
this layer was present close to the edge of the disks.
5. Conclusions
Bioactive glass-ceramics containing leucite, sodium 
calcium silicate and silicorhenanite could be obtained 
using natural raw materials such as quartz and potassium 
feldspar as part of starting components. The apatite layer 
on the L30Bg70 (L/Bg=0.43) glass-ceramic disk was well-
formed and it was the most bioactive sample. However, 
the apatite layer was not well-adhered to the surface of the 
disks because of the higher quantity of leucite in L40Bg60 
(L/Bg=0.66) and L50Bg50 (L/Bg=1.00) glass-ceramics. 
Further studies have to be done to evaluate the possible 
applications of these new types of bioactive materials.
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